Chemotherapy for malignant gliomas

[1] Aoki T, 2006, J NEUROSURG, V105, P385, DOI 10.3171/jns.2006.105.3.385

[2] Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma? [J]. ANTI-CANCER DRUGS, 1999, 10 (10) : 861 - 872

[3] Belanich M, 1996, CANCER RES, V56, P783

[4] Chemotherapy for intracranial ependymomas [J]. CHILDS NERVOUS SYSTEM, 1999, 15 (10) : 563 - 570

[5] Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse [J]. ANNALS OF ONCOLOGY, 2001, 12 (02) : 259 - 266

[6] Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure:: A phase II study [J]. ONCOLOGY, 2002, 63 (01) : 38 - 41

[7] A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiforme [J]. NEUROLOGY, 2002, 58 (12) : 1759 - 1764

[8] Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma [J]. NEURO-ONCOLOGY, 2006, 8 (03) : 253 - 260

[9] Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4746 - 4753

[10] Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2707 - 2714

[1] Aoki T, 2006, J NEUROSURG, V105, P385, DOI 10.3171/jns.2006.105.3.385

[2] Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma? [J]. ANTI-CANCER DRUGS, 1999, 10 (10) : 861 - 872

[3] Belanich M, 1996, CANCER RES, V56, P783

[4] Chemotherapy for intracranial ependymomas [J]. CHILDS NERVOUS SYSTEM, 1999, 15 (10) : 563 - 570

[5] Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse [J]. ANNALS OF ONCOLOGY, 2001, 12 (02) : 259 - 266

[6] Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure:: A phase II study [J]. ONCOLOGY, 2002, 63 (01) : 38 - 41

[7] A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiforme [J]. NEUROLOGY, 2002, 58 (12) : 1759 - 1764

[8] Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma [J]. NEURO-ONCOLOGY, 2006, 8 (03) : 253 - 260

[9] Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4746 - 4753

[10] Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2707 - 2714